Document Security Systems, Inc. manufactures, markets, and sells packaging and security printing solutions. It operates through four segments: Direct Marketing/Online Sales Group, Premier Packaging, Digital Group, and IP Technology. The company offers printed materials, such as folding cartons and paperboard packaging, security paper, vital records, prescription paper, birth certificates, receipts, identification materials, entertainment tickets, secure coupons, and parts tracking forms; custom packaging services; and manufactures, markets, and sells mailers, photo sleeves, sophisticated custom folding cartons, and 3-dimensional direct mail solutions. It also provides AuthentiGuard, a brand authentication application; manages, licenses, and acquires intellectual property assets for monetizing these assets through investments in the development and commercialization of patented technologies, licensing, strategic partnerships, and commercial litigation. In addition, the company invests and acquires companies in the biohealth and biomedical fields; develops open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza; and develops and acquires assets and investments in the securities trading and funds management arena. Further, it operates HWHGIG and HWH Marketplace, which are direct selling platforms that offers health, wealth, and happiness products; and markets and distributes health and wellness products under the Elevate brand; and develops blockchain security technologies for tracking and tracing solutions for supply chain logistics and cyber securities. Additionally, the company develops utility-scale solar farms, and secure living solutions; and provides air and surface purification solutions for commercial and residential markets. Document Security Systems, Inc. was incorporated in 1984 and is headquartered in Victor, New York.
IPO Year:
Exchange: AMEX
Website: dsssecure.com
4 - DSS, INC. (0000771999) (Issuer)
4 - DSS, INC. (0000771999) (Issuer)
4 - DSS, INC. (0000771999) (Issuer)
3 - DSS, INC. (0000771999) (Issuer)
4 - DSS, INC. (0000771999) (Reporting)
4 - DSS, INC. (0000771999) (Issuer)
4 - DSS, INC. (0000771999) (Issuer)
4 - DSS, INC. (0000771999) (Issuer)
3 - DSS, INC. (0000771999) (Issuer)
3 - DSS, INC. (0000771999) (Issuer)
10-Q - DSS, INC. (0000771999) (Filer)
10-K - DSS, INC. (0000771999) (Filer)
8-K - DSS, INC. (0000771999) (Filer)
8-K - DSS, INC. (0000771999) (Filer)
8-K - DSS, INC. (0000771999) (Filer)
8-K - DSS, INC. (0000771999) (Filer)
10-Q - DSS, INC. (0000771999) (Filer)
EFFECT - DSS, INC. (0000771999) (Filer)
S-3/A - DSS, INC. (0000771999) (Filer)
8-K - DSS, INC. (0000771999) (Filer)
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops assets to increase shareholder value, today issued the following letter to shareholders: Dear Esteemed Shareholders, I am pleased to provide you with significant updates regarding the leadership of DSS, Inc. and to outline the strategic direction we are pursuing as a Company. It is with great honor that I announce my appointment as Interim Chief Executive Officer of DSS, Inc., effective August 23, 2024. With over 25 years of experience in leadership roles across diverse sectors—ranging from Chief Operatin
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as Chief Operating Officer of DSS, Inc., brings over 25 years of extensive experience in executive leadership, business development, restructuring, and operations management across a variety of industries. He will succeed Frank D. Heuszel, who is exiting the company to transition to a leadership role within one of its former subsidiaries. Throughout his career, Mr. Grady has held pivotal positions within DSS, including CEO and Director of DSS Biohealth Holdings, President of Premier Packaging Corporation,
ROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) -- DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment of Daniel Lew as Chief Investment Officer and Portfolio Manager. With over three decades of experience in investment management, security analysis, and institutional client advisory, Mr. Lew brings a wealth of knowledge and expertise to his new role. Mr. Lew's distinguished career spans various prestigious financial institutions, where he has held senior investment management positions. Prior to joining DSS Wealth, Inc., he served as a key contributor at AIG SunAmerica, Strong Capital, John Hs
ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced the expansion of its Board of Directors with the appointment of two independent directors, Frankie Wong, a 20-year veteran of public-company financial reporting, and Joanne Wong Hiu Pan, an investment manager with BMI Funds Management Ltd., the leading financial advisor in Hong Kong. Mr. Wong is a certified public accountant in Hong Kong with more than 20 years' practici
The Company added a seasoned executive to its leadership PLAYA VISTA, California, Jan. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Premium Water Corporation (OTC:HIPH) (the "Company") announces that it has appointed Mr. John "JT" Thatch to its Board of Directors as an independent director. Mr. Thatch will be the Company's 4th independent director. Mr. Thatch has a distinguished 20-plus year career as an executive of public markets. Currently Mr. Thatch is the CEO and Vice Chairman of Sharing Services Global Corporation (OTC:SHRG), a Company focused on developing platforms for companies in the direct selling and GIG economy sector. Mr. Thatch is also the lead independent D
McKinnon Has Spent the Past 14 Years Leading Brand Protection Efforts at Global Athletic Brand New Balance Proof Authentication Corporation today announced that Dan McKinnon has been appointed as CEO in connection with its recently closed Series A financing. Prior to joining Proof, Dan was the Head of Global Brand Protection at New Balance, one of the world's largest sports footwear and apparel manufacturers. NYC-based VCFA Group led the round to fund the secondary buyout of DSS Digital, Inc., a leader in anti-counterfeit authentication technology and brand protection solutions, from its parent Document Security Systems, Inc. (NYSE:DSS). The financing will also provide growth capital to he
SC 13D/A - DSS, INC. (0000771999) (Subject)
SC 13D/A - DSS, INC. (0000771999) (Filed by)
SC 13D/A - DSS, INC. (0000771999) (Subject)
SC 13D/A - DSS, INC. (0000771999) (Subject)
SC 13D/A - DSS, INC. (0000771999) (Subject)
SC 13D/A - DSS, INC. (0000771999) (Subject)
SC 13D/A - DSS, INC. (0000771999) (Subject)
SC 13G/A - DSS, INC. (0000771999) (Subject)
SC 13D/A - DSS, INC. (0000771999) (Filed by)
SC 13D/A - DSS, INC. (0000771999) (Filed by)
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, today announced financial results for the first quarter of 2025, highlighting meaningful progress in its financial repositioning and a strong foundation for corporate execution in the coming quarters. In a quarter focused on streamlining operations and financial discipline, DSS delivered significant improvements in key financial metrics: 28% Year-Over-Year Revenue Growth: Total revenues rose sharply, fueled by a 30% increase in printed product sales and a nearly doubling of rental income from the
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sentinel Brokers Company, Inc. ("Sentinel"), a FINRA-registered broker-dealer and a subsidiary of DSS, Inc. (NYSE:DSS), is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA) to act as an underwriter and selling group member for corporate securities offerings. This regulatory milestone significantly enhances Sentinel's capabilities in the capital markets, enabling the firm to participate more fully in initial public offerings (IPOs), follow-on offerings, and a wide array of corporate financing transactions. The approval underscores Sentinel's strategic growth and positions the company to be
ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air purification asset to Impact BioMedical Inc. (NYSE:IBO) in a strategic, all-equity transaction valued at approximately $1.15 million. This divestiture aligns with DSS' ongoing strategy to optimize its portfolio and concentrate on core growth areas. Celios® is a cutting-edge air purification technology featuring a patented three-stage filtration system capable of removing ultrafine particles as small as ten (10) nanometers, helping to improve indoor air quality and mitigate airborne health risks. The sale
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops assets to increase shareholder value, today issued the following letter to shareholders: Dear Esteemed Shareholders, I am pleased to provide you with significant updates regarding the leadership of DSS, Inc. and to outline the strategic direction we are pursuing as a Company. It is with great honor that I announce my appointment as Interim Chief Executive Officer of DSS, Inc., effective August 23, 2024. With over 25 years of experience in leadership roles across diverse sectors—ranging from Chief Operatin
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE:IBO), is delighted to announce the successful pricing of Impact BioMedical's initial public offering (IPO). Impact BioMedical, a trailblazer in advancing human healthcare and wellness solutions, has set its IPO price at $3.00 per share, with an initial offering of 1,500,000 shares. Trading under the ticker symbol "IBO," these shares will begin trading on the NYSE American Market on September 16, 2024. This significant achievement underscores Impact BioMedical's innovative contributions to the healthcare sector and represents a major milestone for DSS. We ar
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- AmericaFirst Funds, a subsidiary of DSS, Inc. (NYSE:DSS), today announced that effective August 9, 2024, David Friedensohn, Monica Himes and Allan Siegel have resigned from their positions as independent directors. The Trust is pleased to announce the election of three new independent directors by shareholder proxy vote: Dr. Prabir Datta, Darryl Robinson and Mark Gronet. These individuals are seasoned senior investment executives who bring a wealth of experience and expertise in asset management, risk management, investment operations and sales. "We are appreciative for the service and commitment by our outgoing directors," said Daniel
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as Chief Operating Officer of DSS, Inc., brings over 25 years of extensive experience in executive leadership, business development, restructuring, and operations management across a variety of industries. He will succeed Frank D. Heuszel, who is exiting the company to transition to a leadership role within one of its former subsidiaries. Throughout his career, Mr. Grady has held pivotal positions within DSS, including CEO and Director of DSS Biohealth Holdings, President of Premier Packaging Corporation,
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a strategic move to bolster shareholder confidence and underscore his commitment to the company's growth. Chairman Chan acquired an additional 672,173 shares of DS, Inc. in an open market transaction on December 28, 2023. Frank Heuszel, CEO of DSS, Inc., expressed his enthusiasm for Mr. Chan's increased stake, viewing it as a strong vote of confidence in the company's strategic direction and future potential. Heuszel said, "Chairman Chan's decis
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the "Reverse Split") of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority shareholders to effect a reverse split by a ratio of not less than 1-for-20 and not more than 1-for-40 (the "Reverse Split Range"), at any time on or before April 20, 2024, with the Board having the discre
NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that its wholly-owned subsidiary, Premier Packaging, signed a contract extension with an existing client for the next three years totaling a minimum of $12 Million with a fourth year extension option bringing the potential total revenue to over $15 Million. Frank D. Heuszel, President and CEO of DSS, Inc., said, "We are very pleased to see that our capital investment to increase production capacity and economies of scale at
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a strategic move to bolster shareholder confidence and underscore his commitment to the company's growth. Chairman Chan acquired an additional 672,173 shares of DS, Inc. in an open market transaction on December 28, 2023. Frank Heuszel, CEO of DSS, Inc., expressed his enthusiasm for Mr. Chan's increased stake, viewing it as a strong vote of confidence in the company's strategic direction and future potential. Heuszel said, "Chairman Chan's decis
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the "Reverse Split") of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority shareholders to effect a reverse split by a ratio of not less than 1-for-20 and not more than 1-for-40 (the "Reverse Split Range"), at any time on or before April 20, 2024, with the Board having the discre
NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that its wholly-owned subsidiary, Premier Packaging, signed a contract extension with an existing client for the next three years totaling a minimum of $12 Million with a fourth year extension option bringing the potential total revenue to over $15 Million. Frank D. Heuszel, President and CEO of DSS, Inc., said, "We are very pleased to see that our capital investment to increase production capacity and economies of scale at
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc. ("the Company" and "Impact") announced today that the Company filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that DSS BioHealth Security, Inc. ("DBH"), a subsidiary of DSS, Inc. (NYSE:DSS), converted substantially all of its 87.5% common stock equity interest in Impact into an equivalent number of Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock can be converted back to Impact common stock 75 days after October 31, 2023. Impact executed a reverse stock split (1 for 55) of its issued and outstanding common stock, but did not effec
NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) announced today that, in a unanimous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia Corp.'s challenge to U.S. Patent No. 6,879,040 (the ‘040 Patent). U.S. Chief Circuit Judge Kimberly Moore, who authored the opinion, and U.S. Circuit Judges Kara Stoll and Tiffany Cunningham sat on the panel for the Federal Circuit. The CAFC appeal mounted by Nichia Corp., a Japanese electronics company, asserted that a 2021 Inter Partes Review (IPR) decision by the USPTO Patent Trial and Appeal Board declaring the ‘040 Patent to be valid should be overturned. The arguments put forth by Nichia were soundly d
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) announced today that Impact BioMedical Inc. ("Impact") filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that Impact effected a reverse stock split of its issued and outstanding common stock by a ratio of 1 for 55. Impact did not effectuate a reverse split of its authorized capital stock and no amendment to the articles of incorporation or bylaws was made. Impact received approval from its majority stockholder and the Company's Board of Directors to effectuate the reverse split. In addition to the reverse split, Impact's Form 8-K discloses DSS BioHealth Security,
NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE:DSS) announced today that the Company received a letter (the "Letter") from the staff of NYSE American LLC (the "Exchange") stating that the Company's securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the NYSE American Company Guide. The Company's continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the Exchange has determined to be no later than April 20, 2024. On October 26, 2023, the Company notified the Exchan
ROCHESTER, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- DSS Wealth Management, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce that Jim Monaghan has joined as Chief Operating Officer and Chief Compliance Officer and Michael Cheah has joined DSS Wealth Management in the role of Portfolio Manager & Head of Fixed Income. Jim Monaghan has joined DSS Wealth Management as Chief Operating Officer and Chief Compliance Officer reporting to Daniel Lew. Mr. Monaghan has over 30 years working in the investment industry holding several leadership positions at industry leading financial firms. He started his career in the annuity busin
ROCHESTER, N.Y., June 30, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend of Impact Biomedical Inc. to DSS Inc. shareholders of record on July 10, 2023, pending SEC clearance. DSS shareholders of record as of 5:00 p.m. ET on July 10, 2023 (the "record date") will be entitled to four (4) shares of Impact Biomedical Inc. for every one (1) share of DSS on the distribution date. The distribution date is to be determined. The distribution is subject to the
ROCHESTER, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend to DSS Inc. shareholders of record on June 30 for distribution on July 14, 2023. DSS shareholders of record as of 4:00 p.m. ET on June 30, 2023 (the "record date") will receive four (4) shares of Impact Biomedical, Inc. for every one (1) share of DSS. About Impact BioMedical, Inc. Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS. Impact BioMedi